<DOC>
	<DOCNO>NCT01471002</DOCNO>
	<brief_summary>The main objective evaluate oncologic efficacy percutaneous cryoablation renal tumor small 4 cm patient renal cancer offer partial nephrectomy . The oncologic outcome assess presence absence residue recurrence follow-up MRI perform first 12 month ( M1 , M3 , M6 , M12 ) .</brief_summary>
	<brief_title>Study Evaluate Efficacy Percutaneous Cryoablation Renal Tumours &lt; 4cm Patients Who Are Not Candidates Partial Nephrectomy</brief_title>
	<detailed_description />
	<mesh_term>Kidney Neoplasms</mesh_term>
	<criteria>Patients follow characteristic : About 75 year , Whatever age : A context familytype tumor ( VHL , hereditary carcinoma , tubulopapillary ... ) ; solitary kidney , tumor easily accessible nephronsparing surgery : Malignant centrohilar intraparenchymal ; local recurrence ( single multiple ) partial nephrectomy ( within limit 3 tumor treat ) ; subject impaired renal function therefore risk severe renal insufficiency ( risk define creatinine clearance 30 ml / min MDRD formula ) ; present contraindication cryoablation treatment . The tumor ( ) meet follow criterion : Presence one three solid tumor native renal parenchyma large diameter le ( equal ) 40 mm , correspond maximum volume 32 cc , measure MRI . A preoperative MRI essential since technique present high sensitivity . This control also give consistency evaluation radiological semiology followup . And its/their location ( ) accessible percutaneous approach . The search metastasis , include thoracic CT scan , negative . Exclusion Criter ia : Partial nephrectomy feasible good technical oncologic condition patient 75 year absence family tumor . Contraindication form sedation . Irreversible coagulopathy Tumor &gt; 4cm Contraindication MRI gadolinium ( proven allergy ) . NB : Patients glomerular filtration rate 30 ml/min/1 , 73 m2 inject single dose macrocyclic gadolinium high thermodynamic stability ( Dotarem Prohance ) , give united recommendation AFSSAPS EMA ( European Medicines Agency ) [ 45 ] . On contrary , linear molecule gadolinium , due low stability , contraindicate risk systemic nephrogenic fibrosis ( FNS ) . Recurrence location procedure perform thermoablation protocol . Biopsy proven benign tumor Predominantly cystic tumor , define necrotic content constitute one third tumor volume Presence endovenous extension , proven secondary extension , visceral lymph node ( especially lung ) . In regard , thoracic CT scan routinely required treatment , accord recommendation urological society . Psychiatric disorder adult guardianship Pregnancy breastfeed Minor patient Legal safeguard Participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>